WEBCAST TRANSMITTED LIVE ON
Saturday, 8 December 2018, 09:00 (CET) from Frankfurt, Germany
Webcast:To View From Your Home or Office, Register at:
www.msddecemberdiabetes2018.com
A replay of the live webcast will begin at 19:00 on 8 December 2018 and will be available for 24 hours.
This program is not intended for health care professionals who practice in, are licensed to practice in, or reside in the U.S., its territories, or Puerto Rico.
Co-Chairs: Juris Meier (Germany), Bernard Zinman (Canada)
agenda | ||
---|---|---|
09:00 – 09:05 | Welcome and Introduction | Co-Chairs |
09:05 – 09:30 | A Look Back and a Look Forward: The Future of Treatment for Patients With Type 2 Diabetes | Pablo Aschner |
09:30 – 09:35 | Q&A | |
09:35 – 10:00 | Ertugliflozin – A Newly Emerging SGLT2 Inhibitor for Patients With Type 2 Diabetes | Samuel Dagogo-Jack |
10:00 – 10:05 | Q&A | |
10:05 – 10:30 | Combination Therapy Treatment – Why It Makes Clinical Sense for Patients With Type 2 Diabetes | Bernard Zinman |
10:30 – 10:35 | Q&A | |
10:35 – 11:05 | Break | |
11:05 – 11:30 | DPP-4 Inhibitors and SGLT2 Inhibitors – A Mechanism for the Future? | David Cherney |
11:30 – 11:35 | Q&A | |
11:35 – 12:35 | Cross-Disciplinary Clinical Considerations: An Interactive Patient Case | Faculty |
12:35 – 12:45 | Closing Remarks | Co-Chairs |